Cover Image
市場調查報告書

角膜乾燥症 (乾眼症):全球臨床實驗檢討

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 237450
出版日期 內容資訊 英文 86 Pages
訂單完成後即時交付
價格
Back to Top
角膜乾燥症 (乾眼症):全球臨床實驗檢討 Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015
出版日期: 2015年01月21日 內容資訊: 英文 86 Pages
簡介

角膜乾燥症特徵是角膜與結膜乾燥,又被稱為眼球乾燥症候群(乾眼症)。角膜乾燥症雖然也可能是因為化學物質造成的燙傷或是熱所引發,但缺乏維他素A也是原因之一。

本報告提供角膜乾燥症 (乾眼症)相關的臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7各國的臨床實驗狀況,地區·Phase (相) ·階段別進展,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 角膜乾燥症 (乾眼症)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: 角膜乾燥症 (乾眼症)臨床實驗數量上眼科系疾病臨床實驗數量所佔的比率

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量: 角膜乾燥症 (乾眼症)臨床實驗數量上眼科系疾病臨床實驗數量所佔的比率

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗 角膜乾燥症 (乾眼症)

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 角膜乾燥症 (乾眼症)治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Novartis AG
    • Allergan, Inc.
    • 參天製藥
    • Valeant Pharmaceuticals International, Inc.
    • Innovative Medical Products
    • 大塚集團
    • Merck & Co., Inc.
    • ORA, Inc.
    • Pfizer Inc.
    • Laboratoires Thea S.A.
  • 有代表性的研究機關/醫院臨床實驗概要
    • 京都府立醫科大學
    • 慶應義塾大學
    • University of Texas Southwestern Medical Center at Dallas
    • Marshall B. Ketchum University
    • Federal University of Sao Paulo
    • Massachusetts Eye and Ear Infirmary
    • Ophthalmic Consultants of Long Island
    • Instituto Universitario de Oftalmobiologia Aplicada
    • Wenzhou Medical College
    • marui眼科

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2528CTIDB

GlobalData's clinical trial report, "Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015" provides data on the Keratoconjunctivitis sicca (Dry Eye) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Keratoconjunctivitis sicca (Dry Eye). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Keratoconjunctivitis sicca (Dry Eye). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Keratoconjunctivitis sicca (Dry Eye)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Keratoconjunctivitis sicca (Dry Eye)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Allergan, Inc.
      • Clinical Trial Overview of Allergan, Inc.
      • Santen Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Santen Pharmaceutical Co., Ltd.
      • Valeant Pharmaceuticals International, Inc.
      • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
      • Innovative Medical Products
      • Clinical Trial Overview of Innovative Medical Products
      • Otsuka Holdings Co., Ltd.
      • Clinical Trial Overview of Otsuka Holdings Co., Ltd.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • ORA, Inc.
      • Clinical Trial Overview of ORA, Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Laboratoires Thea S.A.
      • Clinical Trial Overview of Laboratoires Thea S.A.
    • Clinical Trial Overview of Top Institutes / Government
      • Kyoto Prefectural University of Medicine
      • Clinical Trial Overview of Kyoto Prefectural University of Medicine
      • Keio University
      • Clinical Trial Overview of Keio University
      • University of Texas Southwestern Medical Center at Dallas
      • Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas
      • Marshall B. Ketchum University
      • Clinical Trial Overview of Marshall B. Ketchum University
      • Federal University of Sao Paulo
      • Clinical Trial Overview of Federal University of Sao Paulo
      • Massachusetts Eye and Ear Infirmary
      • Clinical Trial Overview of Massachusetts Eye and Ear Infirmary
      • Ophthalmic Consultants of Long Island
      • Clinical Trial Overview of Ophthalmic Consultants of Long Island
      • Instituto Universitario de Oftalmobiologia Aplicada
      • Clinical Trial Overview of Instituto Universitario de Oftalmobiologia Aplicada
      • Wenzhou Medical College
      • Clinical Trial Overview of Wenzhou Medical College
      • Marui Eye Clinic
      • Clinical Trial Overview of Marui Eye Clinic
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Region, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovative Medical Products, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by ORA, Inc., 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Thea S.A., 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Marshall B. Ketchum University, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts Eye and Ear Infirmary, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ophthalmic Consultants of Long Island, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Universitario de Oftalmobiologia Aplicada, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wenzhou Medical College, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Marui Eye Clinic, 2015*

List of Figures

  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top